Paper · 783201
Arginine-stimulated acute phase of insulin and glucagon secretion in diabetic subjects.
Palmer JP and 3 others. J Clin Invest, 1976. Cited by 188 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Arginine-stimulated acute phase of insulin and glucagon secretion in diabetic subjects. Papers, record 783201. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/783201
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Arginine | Major topic |
| Diabetes Mellitus | Major topic |
| Glucagon | Major topic |
| Insulin | Major topic |
| Adolescent | |
| Adult | |
| Antigens | |
| Diabetes Mellitus, Type 1 | |
| Dose-Response Relationship, Drug | |
| Female | |
| Glucose | |
| Humans | |
| Insulin Secretion | |
| Islets of Langerhans | |
| Male | |
| Stimulation, Chemical |
Source PubMed
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials2
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record | Source |
|---|---|---|---|---|
| NCT02684929 | Effects of Chronic Dietary Exposure to Branched Chain Amino Acids | Background | ClinicalTrials.gov | |
| NCT02697305 | Incretin Effects of Branched Chain Amino Acids | Background | ClinicalTrials.gov |
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References28
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 5,687,345 | Early phase of insulin release. | Diabetes | 1968 | https://conductscience.org/library/papers/5687345 | PubMed |
| 2 | 4,131,886 | A unifying hypothesis for hereditary and acquired diabetes. | Lancet | 1974 | https://conductscience.org/library/papers/4131886 | PubMed |
| 3 | 4,153,713 | The effect of adrenergic blockade on the glucagon responses to starvation and hypoglycemia in man. | J Clin Invest | 1974 | https://conductscience.org/library/papers/4153713 | PubMed |
| 4 | 4,373,494 | Glucagon secretion from the perfused rat pancreas. Studies with glucose and catecholamines. | J Clin Invest | 1974 | https://conductscience.org/library/papers/4373494 | PubMed |
| 5 | 4,581,053 | Lack of glucagon response to hypoglycemia in diabetes: evidence for an intrinsic pancreatic alpha cell defect. | Science | 1973 | https://conductscience.org/library/papers/4581053 | PubMed |
| 6 | 4,598,090 | Clinical control of diabetes by the artificial pancreas. | Diabetes | 1974 | https://conductscience.org/library/papers/4598090 | PubMed |
| 7 | 4,598,089 | An artificial endocrine pancreas. | Diabetes | 1974 | https://conductscience.org/library/papers/4598089 | PubMed |
| 8 | 4,555,783 | Acute and steady-state insulin responses to glucose in nonobese diabetic subjects. | J Clin Invest | 1972 | https://conductscience.org/library/papers/4555783 | PubMed |
| 9 | 4,552,828 | Decreased sensitivity of the pancreatic beta cells to glucose in prediabetic and diabetic subjects. A glucose dose-response study. | Diabetes | 1972 | https://conductscience.org/library/papers/4552828 | PubMed |
| 10 | 4,438,348 | Concentrations of glucagon and the insulin:glucagon ratio in the portal and peripheral circulation. | Proc Soc Exp Biol Med | 1974 | https://conductscience.org/library/papers/4438348 | PubMed |
1 to 10 of 28
See all 28 referencesCited by42
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 188 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,595,807 | Diminished arginine bioavailability during hyperglycaemia distinguishes individuals with A-β+ ketosis-prone diabetes from those with type 2 diabetes: implications for the pathogenesis of ketoacidosis in A-β+ ketosis-prone diabetes. | Diabetologia | 2026 | https://conductscience.org/library/papers/42595807 | PubMed |
| 41,644,541 | Development of a severe rat refeeding syndrome model and mathematical modeling of the associated hypophosphatemia. | NPJ Syst Biol Appl | 2026 | https://conductscience.org/library/papers/41644541 | PubMed |
| 37,512,487 | Low Fasting Concentrations of Glucagon in Patients with Very Long-Chain Acyl-CoA Dehydrogenase Deficiency. | Metabolites | 2023 | https://conductscience.org/library/papers/37512487 | PubMed |
| 37,166,980 | Short-term fasting lowers glucagon levels under euglycemic and hypoglycemic conditions in healthy humans. | JCI Insight | 2023 | https://conductscience.org/library/papers/37166980 | PubMed |
| 36,187,117 | Mathematical model of insulin kinetics accounting for the amino acids effect during a mixed meal tolerance test. | Front Endocrinol (Lausanne) | 2022 | https://conductscience.org/library/papers/36187117 | PubMed |
| 35,657,690 | Cross Talk Between Insulin and Glucagon Receptor Signaling in the Hepatocyte. | Diabetes | 2022 | https://conductscience.org/library/papers/35657690 | PubMed |
| 35,399,942 | A Hypothesis From Metabolomics Analysis of Diabetic Retinopathy: Arginine-Creatine Metabolic Pathway May Be a New Treatment Strategy for Diabetic Retinopathy. | Front Endocrinol (Lausanne) | 2022 | https://conductscience.org/library/papers/35399942 | PubMed |
| 34,999,111 | Insulin regulates arginine-stimulated insulin secretion in humans. | Metabolism | 2022 | https://conductscience.org/library/papers/34999111 | PubMed |
| 34,203,642 | Egg White Protein Feeding Facilitates Skeletal Muscle Gain in Young Rats with/without Clenbuterol Treatment. | Nutrients | 2021 | https://conductscience.org/library/papers/34203642 | PubMed |
| 34,003,799 | C-peptide enhances glucagon secretion in response to hyperinsulinemia under euglycemic and hypoglycemic conditions. | JCI Insight | 2021 | https://conductscience.org/library/papers/34003799 | PubMed |
1 to 10 of 42
See all 42 cited byGenes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| GCG | 2,641 | PubTator's text mining | https://conductscience.org/library/genes/2641 | NCBI Gene |
| INS | 3,630 | PubTator's text mining | https://conductscience.org/library/genes/3630 | NCBI Gene |
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/783201
GET https://conductscience.org/api/papers/v1/783201/references?page=2